Cancer Biotherapy and Radiopharmaceuticals · 2015 · 36 citations · 21 references
MedicineCancer BiologyOncologyGene ExpressionMolecular OncologyNeuro-oncologyBrain TumorsCancer BiomarkersMalignant NeoplasmsMicrorna BiologyMicrorna-mediated RegulationMolecular Tumor ProfilingGlioma GradingMicrorna BiomarkersMicrorna Expression ProfilingMicrorna In CancerMicrorna Prognostic MarkersPrognostic Value Of GradeReal-time Polymerase Chain Reaction (Pcr)Real-time Polymerase Chain Reaction Assays
MicroRNA-15b (miR-15b) has been demonstrated to suppress proliferation by arresting cell cycle progression and inducing apoptosis in glioma cells. However, the prognostic value of miR-15b expression in human gliomas remains unclear. In the present study, the authors examined the expression profile in glioma specimens and the prognostic value of miR-15b in patients with gliomas. Real-time polymerase chain reaction assay was employed to detect the expression levels of miR-15b in 92 glioma tissues categorized by World Health Organization (WHO) histopathological grades. However, the prognostic value of miR-15b in human glioma has not been evaluated yet. MiR-15b expression in human glioma tissues was distinctly lower than in normal brain tissues. Furthermore, the expression of miR-15b notably decreased with the ascending histopathological grade of gliomas. Additionally, Kaplan-Meier survival analysis showed that low miR-15b expression was associated with poor overall survival in patients with gliomas. Similarly, miR-15b reduction occurred with increasing frequency in glioma patients with lower Karnofsky performance scale (KPS) scores than in those with higher KPS scores. No significant difference was observed between miR-15b expression and gender, age, and tumor location. These findings revealed that a lower expression level of miR-15b was closely related to a shorter overall survival, suggesting that miR-15b could be an intrinsic factor that plays an important role in the malignant progression of gliomas.
21
Roger Stupp, Monika E. Hegi, Warren Mason et al. · The Lancet Oncology · 2009 · 7.8K citations
<i>IDH1</i>and<i>IDH2</i>Mutations in Gliomas
Hai Yan, D. Williams Parsons, Genglin Jin et al. · New England Journal of Medicine · 2009 · 5.9K citations · Full text
microRNA-21 promotes tumor proliferation and invasion in gastric cancer by targeting PTEN
Bao Gui Zhang, Jian Fang Li, Bei Yu et al. · Oncology Reports · 2012 · 292 citations · Full text